loadpatents
name:-0.012312173843384
name:-0.021697044372559
name:-0.0037069320678711
Goel; Om P Patent Filings

Goel; Om P

Patent Applications and Registrations

Patent applications and USPTO patent grants for Goel; Om P.The latest application filed is for "5-substituted 2,4-thiazolidinediones (thiohydantoins). pseudothiohydantoins, and propseudothiohydantoins for use as antiviral ag".

Company Profile
0.19.16
  • Goel; Om P - Ann Arbor MI
  • Goel; Om P. - Ann Arbor MI
  • Goel; Om P. - Ann Harbor MI
  • Goel; Om P. - Detroit MI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
5-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents
Grant 11,202,774 - Goel December 21, 2
2021-12-21
5-substituted 2,4-thiazolidinediones (thiohydantoins). Pseudothiohydantoins, And Propseudothiohydantoins For Use As Antiviral Ag
App 20200237729 - Goel; Om P
2020-07-30
5-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents
Grant 10,646,477 - Goel
2020-05-12
NSAID derivatives of omega-3 polyunsaturated acids as gamma secretase modulators
Grant 10,125,078 - Goel November 13, 2
2018-11-13
Omefibrates for Treating Dyslipidemia and Cardiovascular Disease
App 20170327455 - Goel; Om P.
2017-11-16
Metformin salts to treat Type2 diabetes
Grant 9,815,777 - Goel November 14, 2
2017-11-14
Formulations of concentrated prunes and prebiotics as laxatives and dietary supplements
Grant 9,808,497 - Goel November 7, 2
2017-11-07
Omegabalins, GABA derivatives of omega-3 polyunsaturated acids, their formulations and methods of use
Grant 9,688,613 - Goel June 27, 2
2017-06-27
Statins of omega-3 polyunsaturated acids for treating hypercholesterolemia
Grant 9,540,307 - Goel January 10, 2
2017-01-10
Omegabalins, GABA Derivatives of Omega-3 Polyunsaturated Acids, Their Formulations and Methods of Use
App 20160376223 - Goel; Om P.
2016-12-29
Metformin Salts To Treat Type2 Diabetes
App 20160229796 - Goel; Om P
2016-08-11
Thiazolidinediones of omega-3 polyunsaturated acids as new insulin sensitizers for treating type2 diabetes
Grant 9,364,465 - Goel June 14, 2
2016-06-14
Thiazolidinediones of Omega-3 Polyunsaturated Acids as New Insulin Sensitizers for Treating Type2 Diabetes
App 20160051521 - Goel; Om P
2016-02-25
Ascorbate Esters of Omega-3 Fatty Acids and Their Formulations and Uses
App 20150374660 - Goel; Om P
2015-12-31
Omefibrates for Treating Dyslipidemia and Cardiovascular Disease
App 20150344402 - Goel; Om P.
2015-12-03
Statins of Omega-3 Polyunsaturated Acids for Treating Hypercholesterolemia
App 20150322032 - Goel; Om P
2015-11-12
Formulations of Concentrated Prunes and Prebiotics as Laxatives and Dietary Supplements
App 20140308374 - Goel; Om P
2014-10-16
Zinc complexes of natural amino acids for treating elevated copper caused toxicities
Grant 8,247,398 - Goel August 21, 2
2012-08-21
Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses
Grant 8,049,038 - Goel November 1, 2
2011-11-01
Carnitine Conjugates Of Adamantanamines Derivatives As Dual Prodrugs For Various Uses
App 20110212166 - Goel; Om P.
2011-09-01
Carnitine conjugates of adamantanamines and neramexane derivatives as dual prodrugs for various uses
Grant 7,977,511 - Goel July 12, 2
2011-07-12
Adamantanamines and neramexane salts of thiomolybdic and thiotungstic acids
Grant 7,893,289 - Goel February 22, 2
2011-02-22
Adamantanamines and Neramexane Salts of Thiomolybdic and Thiotungstic Acids
App 20100216775 - Goel; Om P.
2010-08-26
Production of carnitine conjugate intermediates
Grant 7,777,071 - Goel August 17, 2
2010-08-17
Methods of treating diabetes using carnitine conjugates as dual prodrugs
Grant 7,718,696 - Goel May 18, 2
2010-05-18
Carnitine Conjugates of Adamantanamines and Neramexane Derivatives as Dual Prodrugs for Various Uses
App 20090246267 - Goel; Om P.
2009-10-01
Carnitine Conjugates As Dual Prodrugs, Methods Of Production And Uses Thereof
App 20090012160 - Goel; Om P
2009-01-08
Zinc complexes of natural amino acids for treating elevated copper caused toxicities
App 20080200443 - Goel; Om P.
2008-08-21
Methods of treating various diseases using carnitine conjugates as dual prodrugs
App 20080188444 - Goel; Om P.
2008-08-07
Carnitine conjugates as dual prodrugs and uses thereof
Grant 7,345,190 - Goel March 18, 2
2008-03-18
Novel carnitine conjugates as dual prodrugs and uses thereof
App 20050101572 - Goel, Om P.
2005-05-12
Amino acid complexes of cobalt (III) mesoporphyrin IX and cobalt (III) protoporphyrin IX
Grant 5,929,064 - Goel , et al. July 27, 1
1999-07-27
Process for the preparation of D(-) and L(+)-3,3-diphenylalanine and D(-) and L(+)-substituted 3,3-diphenylalanines and derivatives thereof
Grant 5,198,548 - Beylin , et al. March 30, 1
1993-03-30
Process for the resolution of 1-aminoindanes
Grant 4,833,273 - Goel May 23, 1
1989-05-23
Trialkylsilyl esters of 6(substituted amino)phenyl-1,-dihydro-2-oxonicotinic acid, methods for their production and conversion to the corresponding acid chlorides
Grant 3,951,982 - Goel April 20, 1
1976-04-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed